Cargando…
Jian Pi Tiao Gan Yin alleviates obesity phenotypes through mTORC1/SREBP1 signaling in vitro and in vivo
BACKGROUND: Obesity has been considered as a leading cause of multiple metabolic syndromes, such as type 2 diabetes and hypertension cardiovascular diseases. Jian Pi Tiao Gan Yin (JPTGY), a Chinese herb preparation, is used to treat obesity of liver qi stagnation and spleen deficiency. The mechanism...
Autores principales: | Song, Xiaoming, Han, Lulu, Lin, Xiaowan, Tian, Minghui, Sun, Fenglei, Feng, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011225/ https://www.ncbi.nlm.nih.gov/pubmed/35433951 http://dx.doi.org/10.21037/atm-22-685 |
Ejemplares similares
-
Mechanisms of the Jian Pi Tiao Gan Yin in the treatment of simple obesity revealed by network pharmacology
por: Tian, Minghui, et al.
Publicado: (2022) -
Traditional Chinese Medicine Formula Jian Pi Tiao Gan Yin Reduces Obesity in Mice by Modulating the Gut Microbiota and Fecal Metabolism
por: Dong, Wenchao, et al.
Publicado: (2022) -
Yin-and-Yang of mTORC1/C2 in Angelman syndrome mice
por: Bi, Xiaoning, et al.
Publicado: (2015) -
SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
por: Porstmann, Thomas, et al.
Publicado: (2008) -
Oncogenic signaling upstream of mTORC1 drives lipogenesis and proliferation through SREBP
por: Ricoult, Stéphane, et al.
Publicado: (2014)